Corcept Therapeutics Incorporated (NASDAQ: CORT) faces a securities class action lawsuit following a 50% stock decline after the Food and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE